LipoScience, Inc.
Morrisville, NC, US· latest recorded location
LipoScience, Inc. is named on 36 US grants and 45 published applications in this corpus. Its most frequent classification is G01N (Investigating or analysing materials by determining their chemical or physical properties).
- Granted patents
- 36
- Published applications
- 45
- Inventors
- 22
- Granted in 2026 so far
- 0
- Most recent grant
- 29 Oct 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 4 | 2 |
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 1 |
| 2007 | 1 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 1 |
| 2011 | 1 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 6 |
| 2014 | 1 | 1 |
| 2015 | 0 | 3 |
| 2016 | 5 | 2 |
| 2017 | 4 | 5 |
| 2018 | 1 | 2 |
| 2019 | 4 | 2 |
| 2020 | 2 | 4 |
| 2021 | 3 | 2 |
| 2022 | 1 | 4 |
| 2023 | 3 | 0 |
| 2024 | 4 | 5 |
| 2025 | 0 | 1 |
By publication year.
Technology areas
Share of 81 documents
- G01NInvestigating or analysing materials by determining their chemical or physical properties67
- G01RMeasuring electric variables67
- G16HHealthcare informatics, i.e. information and communication technology [ict] specially adapted for the49
- A61BMedical diagnosis and surgery33
- G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or21
- G16ZInformation and communication technology [ict] specially adapted for specific application fields, not15
- Y10TTechnical subjects covered by former us classification11
- G06FComputing and data processing9
- G16CComputational chemistry5
- G01KMeasuring temperature3
Recent patents
- NMR system and methods for multi-parameter metabolic vulnerability index evaluations29 Oct 2024US 12,130,295 B2
- Cardiovascular risk evaluations using a risk parameter that includes an HDL and inflammatory biomarker interaction parameter21 May 2024US 11,988,679 B2
- Multiple-marker risk parameters predictive of conversion to diabetes21 May 2024US 11,990,243 B2
- Methods, systems and computer programs for assessing CHD risk using adjusted HDL particle number measurements26 Mar 2024US 11,942,187 B2
- NMR quantification of TMAO10 Oct 2023US 11,782,002 B2
- Multi-parameter metabolic vulnerability index evaluations9 Jan 2025US 2025/0012820 A1
- Cardiovascular Risk Evaluations Using a Risk Parameter That Includes an HDL and Inflammatory Biomarker Interaction Parameter12 Sep 2024US 2024/0302389 A1
- Multiple-Marker Risk Parameters Predictive of Conversion to Diabetes12 Sep 2024US 2024/0304336 A1
- Methods, Systems and Computer Programs for Assessing CHD Risk Using Adjusted HDL Particle Number Measurements5 Sep 2024US 2024/0296902 A1
- NMR Quantification of TMAO18 Apr 2024US 2024/0125719 A1
Most cited
By later US patents
- Methods, systems, and computer program products for analyzing and presenting NMR lipoprotein-based risk assessment results42US 6,576,471 B22003
- Methods and computer program products for determining risk of developing type 2 diabetes and other insulin resistance related disorders35US 6,518,069 B12003
- Method of determining presence and concentration of lipoprotein X in blood plasma and serum30US 6,617,167 B22003
- Methods, systems and computer programs for deconvolving the spectral contribution of chemical constituents with overlapping signals30US 7,243,030 B22007
- Methods, systems and computer programs for assessing CHD risk using adjusted LDL particle number measurements24US 7,790,465 B22010